Home  >  Products  >  GLIPR1 (GLI pathogenesis-related 1 ) Blocking Peptide (the middle region of GLIPR1)(100ug)
GLIPR1 (GLI pathogenesis-related 1 ) Blocking Peptide (the middle region of GLIPR1)(100ug)

GLIPR1 (GLI pathogenesis-related 1 ) Blocking Peptide (the middle region of GLIPR1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GLIPR1 Antibody (ARP64655_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64655
Size: 100ug
Weight: 28kDa
Gene: 11010
Format: Lyophilized powder
Target: This gene encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family. Increased expression of this gene is associated with myelomocytic differentiation in macrophage and decreased expression of this gene through gene methylation is associated with prostate cancer. The protein has proapoptotic activities in prostate and bladder cancer cells. This gene is a member of a cluster on chromosome 12 containing two other similar genes. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized.
Alternative names: CRISP7; GLIPR; RTVP1
See Full Product Listings >